ChromaDex Corp. (CDXC)

[MinnieM]

I found an interesting comment posted on my last article by Lane Simonian, an SA Contributor. Following is his comment:

http://seekingalpha.com/article/4040764-chromadex-response-claim-niagen-just-expensive-vitamin-b3#comment-74388935

The decline in NAD+ is an important factors in the progression of Alzheimer's disease. Not only is the result a decline in cellular energy it also lowers levels of reduced glutathione [GSH in chart below] which is a critical antioxidant in the brain. Without glutathione, the brain has little ability to protect itself against oxidative stress.

https://atlasofscience.org/glutathione-a-molecular-whistleblower-for-alzheimers-disease/


The following chart is critical for understanding the pathway that triggers and leads to the progression of Alzheimer's disease.

http://www.frontiersin.org/files/Articles/131867/fncel-09-00091-HTML/image_m/fncel-09-00091-g003.jpg

Efforts to increase NAD+ levels may therefore be helpful in the treatment of Alzheimer's disease.